Copyright
©The Author(s) 2023.
World J Diabetes. Aug 15, 2023; 14(8): 1178-1193
Published online Aug 15, 2023. doi: 10.4239/wjd.v14.i8.1178
Published online Aug 15, 2023. doi: 10.4239/wjd.v14.i8.1178
Type 2 diabetes mellitus | Gestational diabetes mellitus | |
Occurrence | Generally, develops after age 40, but can occur at any age | Develops during pregnancy, typically after the 20th wk of gestation |
Prevalence | Affects approximately 90% of people with diabetes | Affects approximately 2%-10% of pregnancies |
Risk factors | Family history, obesity, physical inactivity, high blood pressure, and ethnicity | Family history, previous history of gestational diabetes, obesity, older maternal age, and certain ethnicities |
Symptoms | Fatigue, increased thirst, frequent urination, blurred vision, slow healing wounds | Often asymptomatic, but may cause increased thirst, frequent urination, and increased hunger |
Diagnosis | Blood tests measuring fasting blood glucose and hemoglobin A1C levels | Oral glucose tolerance test usually performed between 24-28 wk of gestation |
Treatment | Lifestyle changes, medication, and/or insulin therapy | Lifestyle changes, close monitoring of blood glucose levels, and medication/insulin therapy if necessary |
Potential complications | Cardiovascular disease, neuropathy, retinopathy, kidney disease, and foot ulcers | Preeclampsia, premature delivery, macrosomia, and increased risk of developing type 2 diabetes later in life |
- Citation: Mendez Y, Alpuing Radilla LA, Delgadillo Chabolla LE, Castillo Cruz A, Luna J, Surani S. Gestational diabetes mellitus and COVID-19: The epidemic during the pandemic. World J Diabetes 2023; 14(8): 1178-1193
- URL: https://www.wjgnet.com/1948-9358/full/v14/i8/1178.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i8.1178